⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT November 27, 2025

Blopress Plus 32 mg/25 mg - Tabletten 32/25 mg/mg (Tablette)

📷 Wikipedia: Hydrochlorothiazide · Source
Blopress Plus 32 mg/25 mg - Tabletten 32/25 mg/mg (Tablette)
📷 Wikipedia: Hydrochlorothiazide · Source
Blopress Plus 32 mg/25 mg tablets are temporarily unavailable due to a halt in distribution. No new supply is expected until December 5, 2028.
🗄
Archived (older alert)
This alert was reported 288 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
116 days in total
May 18, 2026 September 11, 2026

What is this? Blopress Plus is a tablet that contains two medicines: candesartan and hydrochlorothiazide. It is used for blood pressure.

What's happening? The tablets are not available right now. The company stopped making them for a while.

Does this affect me? If you take Blopress Plus, you may not be able to get it until late 2028.

What should I do? Ask your pharmacist or doctor for another blood-pressure medicine that works for you.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Agency-published detail

🚫 Parallel export ban active · ATC: C09DA06 · Reason: Vorübergehende Einstellung des Inverkehrbringens · Marketing authorisation holder: Cheplapharm Arzneimittel GmbH, Ziegelhof 24, 17489 Greifswald, Federal Republic of Germany · Affected packs: 28 Stück Schachtel [Nicht verfügbar, since 2025-12-06, resupply 2028-12-05]

First published
November 27, 2025
Last refreshed by us
3 months ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Low AT 3 days ago

Candecam 8 mg/5 mg Tabletten 8/5 mg/mg (Tablette)

ATC: C09DB07 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: HCS B.V., Hendrik Kennisstraat 53, 2650 Edegem, Kingdom of Belgium · Affected packs: 28 Stück Schachtel, Bliste...
Low AT 3 days ago

Lisinopril-HCT ratiopharm - Tabletten (Tablette)

🚫 Parallel export ban active · ATC: C09BA03 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Teva B.V., Swensweg 5, 2031 GA Haarlem, Niederlande · Affected packs: 30 Stück...
Low AT 3 days ago

Ramipril-HCT ratiopharm 2,5 mg/ 12,5 mg - Tabletten 2,5 mg/12,5 mg (Tablette)

ATC: C09BA05 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Teva B.V., Swensweg 5, 2031 GA Haarlem, Niederlande · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht...
Low AT 3 days ago

Amlodipin/Valsartan/Hydrochlorothiazid ratiopharm 5 mg/160 mg/12,5 mg Filmtabletten 5/160/12,5 mg (Filmtablette)

ATC: C09DX01 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Teva B.V., Swensweg 5, 2031 GA Haarlem, Niederlande · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht...
Low AT 1 week ago

Amlodipin/Valsartan/HCT Sandoz 5 mg/160 mg/25 mg – Filmtabletten 5/160/25 mg (Filmtablette)

Parallel export is banned for this medicine. It is unavailable due to manufacturing capacity shortages.
Low AT resolved 3 weeks ago

Ramipril/HCT Hexal 5 mg/25 mg - Tabletten 5 mg/25 mg (Tablette)

Ramipril/HCT Hexal 5 mg/25 mg tablets are currently unavailable due to manufacturing capacity issues.
Low AT resolved 3 weeks ago

Ramipril/HCT 1A Pharma 5 mg/25 mg - Tabletten 5 mg/25 mg (Tablette)

Ramipril/HCT 1A Pharma 5 mg/25 mg tablets are unavailable due to manufacturing capacity issues.
Low AT 3 weeks ago

Amlodipin/Valsartan/HCT Sandoz 5 mg/160 mg/12,5 mg – Filmtabletten 5/160/12,5 mg (Filmtablette)

Amlodipin/Valsartan/HCT Sandoz 5 mg/160 mg/12.5 mg film-coated tablets are subject to a parallel export ban. Supply is restricted due to manufacturing capacity shortages.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Blopress Plus 32 mg/25 mg - Tabletten 32/25 mg/mg (Tablette). Blopress Plus 32 mg/25 mg tablets are temporarily unavailable due to a halt in distribution. No new supply is expected until December 5, 2028.
▸ When was this alert issued?
This alert was issued on November 27, 2025 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.